a month ago
CATX
AnalystsGregory RenzaGregory Renza's Stock Forecasts
AnalystsGregory Renza
Analyst Ranking
Top 2%
#94 out of 5163 analysts
Average Return
+24.94%
Win Rate
46%115 out of 248
Risk vs Reward
Poor
Good
Gregory Renza's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +1,085.19% | $18.63 | $220.80 | 2025-05-09 - 2025-12-30 | Buy |
Cidara Therapeutics IncCDTX | +864.38% | $22.88 | $220.65 | 2024-12-13 - 2025-12-12 | Buy |
Cidara Therapeutics IncCDTX | +809.39% | $24.28 | $220.80 | 2025-05-23 - 2025-12-30 | Buy |
Prometheus Biosciences IncRXDX | +603.13% | $27.52 | $193.50 | 2022-05-13 - 2023-04-18 | Buy |
Alpine Immune Sciences IncALPN | +428.30% | $12.19 | $64.40 | 2023-10-05 - 2024-04-11 | Buy |
Gregory Renza Analyst Color
Get additional color on Gregory Renza's coverage of popular stocks
a month ago
NRIX
a month ago
GILD
a month ago
ONC
3 years ago
RXDX
Gregory Renza's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Agios Pharmaceuticals IncAGIO | 8 | Strong Buy | $38.00 | +39.04% | Maintains | 8 days ago |
Fulcrum Therapeutics IncFULC | 5 | Strong Buy | $18.00 | +58.73% | Maintains | 21 days ago |
Regeneron Pharmaceuticals IncREGN | 1 | Strong Buy | $798.00 | +3.11% | Assumes | a month ago |
Perspective Therapeutics IncCATX | 7 | Strong Buy | $12.00 | +337.96% | Assumes | a month ago |
Nurix Therapeutics IncNRIX | 12 | Strong Buy | $30.00 | +57.73% | Assumes | a month ago |
Gilead Sciences IncGILD | 1 | Strong Buy | $140.00 | +13.65% | Assumes | a month ago |
Amgen IncAMGN | 18 | Hold | $318.00 | -3.25% | Assumes | a month ago |
Xencor IncXNCR | 10 | Strong Buy | $29.00 | +92.95% | Initiates Coverage On | a month ago |
Viridian Therapeutics IncVRDN | 12 | Strong Buy | $41.00 | +32.17% | Initiates Coverage On | a month ago |
Nuvation Bio IncNUVB | 7 | Strong Buy | $11.00 | +23.04% | Initiates Coverage On | a month ago |
Nuvalent IncNUVL | 1 | Strong Buy | $140.00 | +39.47% | Initiates Coverage On | a month ago |
Mannkind CorpMNKD | 2 | Strong Buy | $9.00 | +59.01% | Initiates Coverage On | a month ago |
Ideaya Biosciences IncIDYA | 13 | Strong Buy | $59.00 | +70.96% | Initiates Coverage On | a month ago |
Cg Oncology IncCGON | 4 | Strong Buy | $62.00 | +54.34% | Initiates Coverage On | a month ago |
Bicycle Therapeutics PLCBCYC | 4 | Hold | $10.00 | +47.06% | Initiates Coverage On | a month ago |
Beone Medicines LtdONC | 3 | Strong Buy | $400.00 | +31.27% | Initiates Coverage On | a month ago |
Ascentage Pharma Group InternationalAAPG | 1 | Strong Buy | $51.00 | +95.63% | Initiates Coverage On | a month ago |
Abivax SaABVX | 1 | Strong Buy | $140.00 | +1.20% | Initiates Coverage On | a month ago |
Exelixis IncEXEL | 11 | Hold | $50.00 | +13.53% | Downgrades | 6 months ago |
Cidara Therapeutics IncCDTX | 3 | Buy | $35.00 | -84.15% | Maintains | 7 months ago |
Acadia Pharmaceuticals IncACAD | 14 | Buy | $26.00 | -2.62% | Reiterates | 7 months ago |
Adc Therapeutics SaADCT | 12 | Buy | $8.00 | +128.57% | Reiterates | 8 months ago |
Inovio Pharmaceuticals IncINO | 11 | Hold | $5.00 | +184.09% | Reiterates | 8 months ago |
Jazz Pharmaceuticals PLCJAZZ | 14 | Buy | $172.00 | +0.69% | Maintains | 8 months ago |
Spruce Biosciences IncSPRB | 13 | Hold | $0.50 | -99.40% | Maintains | 9 months ago |
Cormedix IncCRMD | 6 | Buy | $12.00 | -3.85% | Reiterates | 9 months ago |
Verastem IncVSTM | 10 | Buy | $14.00 | +85.68% | Maintains | 9 months ago |
Pacira Biosciences IncPCRX | 11 | Hold | $18.00 | -30.96% | Reiterates | a year ago |
Jasper Therapeutics IncJSPR | 4 | Buy | $48.00 | +2,581.56% | Maintains | a year ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $2.00 | N/A | Maintains | a year ago |
Verrica Pharmaceuticals IncVRCA | 7 | Hold | $20.00 | N/A | Downgrades | a year ago |
Atyr Pharma IncATYR | 6 | Buy | $16.00 | N/A | Reiterates | a year ago |
Morphic Holding IncMORF | 7 | Hold | $57.00 | N/A | Reiterates | a year ago |
Alpine Immune Sciences IncALPN | 4 | Hold | $65.00 | N/A | Downgrades | 2 years ago |
Fusion Pharmaceuticals IncFUSN | 3 | Hold | $21.00 | N/A | Downgrades | 2 years ago |
Aptose Biosciences IncAPTOF | 7 | Buy | $540.00 | N/A | Maintains | 2 years ago |
Avalo Therapeutics IncAVTX | 4 | Hold | $180.00 | N/A | Downgrades | 3 years ago |
Bellus Health IncBLU | 8 | Hold | $14.75 | N/A | Reiterates | 3 years ago |
Prometheus Biosciences IncRXDX | 6 | Hold | $200.00 | N/A | Maintains | 3 years ago |
Seagen IncSGEN | 5 | Buy | $229.00 | N/A | Maintains | 3 years ago |
Global Blood Therapeutics IncGBT | 3 | Hold | $68.50 | N/A | Downgrades | 3 years ago |
Aprea Therapeutics IncAPRE | 5 | Hold | $80.00 | N/A | Maintains | 4 years ago |
Provention Bio IncPRVB | 2 | Hold | $10.00 | N/A | Downgrades | 5 years ago |
Iterum Therapeutics PLCITRM | 3 | Hold | $30.00 | N/A | Downgrades | 6 years ago |
Portola Pharmaceuticals IncPTLA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Arqule IncARQL | 1 | Hold | $20.00 | N/A | Downgrades | 6 years ago |
Gamida Cell LtdGMDAQ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.